Matrix Regulation of Cell Function During Wound Healing
伤口愈合过程中细胞功能的基质调节
基本信息
- 批准号:7267693
- 负责人:
- 金额:$ 26.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-08-01 至 2009-09-29
- 项目状态:已结题
- 来源:
- 关键词:AddressAdhesionsCell physiologyCellular biologyCicatrixClinicalCutaneousFibroblastsFibronectinsFibrosisFoundationsGoalsHealedHistologyHumanImmunohistochemistryImpairmentIn VitroIntegrinsMechanical StressMechanicsMediatingModelingMusMyofibroblastNormal tissue morphologyPatientsProcessProteinsRangeRegulationResearch PersonnelSeriesSignal TransductionSignaling ProteinSpecificityTestingTissuesTransforming Growth Factor betaWaterWild Type MouseWorkWound Healinghealingin vivonovel therapeuticsprogramsresearch studyrho GTP-Binding Proteinstissue regenerationwound
项目摘要
Pathogenic scarring and fibrosis represent important clinical problems with potentially serious
consequences or patients, including impairment of normal tissue regeneration and neighboring tissue
function. Our long-term goal is to identify the critical regulatory mechanisms that govern fibroblast
differentiation Into myofibroblasts thereby developing novel strategies to control scarring and fibrosis. TGF-
~ is a central component of this mechanism and we recently determined that a focal adhesion protein,
termed Hic-5, is induced by TGF-~ in normal human dermal fibroblasts; Hic-5 is also persistently expressed
in hypertrophic scar myofibroblasts (HTSF). Importantly, Hic-5 is required for TGF-~ production in HTSF
thereby regulating its own expression via the TGF-~ autocrine loop. Moreover, when Hic-5 is knocked down
with RNAi the HTSF phenotype reverts to that of a normal dermal fibroblast supporting a therapeutic
strategy of blocking fibrosis by targeting Hic-5 expression in myofibroblasts. We propose a two-year,
ARRA sponsored, research program in which we test the hypothesis that TGF-~ induces Hic-5 expression
through Rho GTPase-dependent pathway(s) thereby establishing an autocrine loop and a persistent
myofibroblast phenotype. In Aim 1, we will define the intracellular pathways that regulate TGF-~-dependent,
Hic-5 expression in myofibroblasts. The mechanisms through which Hic-5 is induced in normal human
fibroblasts and perpetuated in pathogenic fibroblasts (HTSFs)
will be determined. Experiments will be performed using pharmacological inhibitors, genetic silencing
(RNAi) and cDNA reconstitution, in vitro. The levels of Hic-5 and candidate signaling molecules will be
determined and changes in activity measured using phosphorylation-specific antibodies. In Aim 2, we will
identify and analyze Hic-,5 regulated genes in hypertrophic scars. Expression (cDNA) arrays will be used
to identify the genes products in HTSF that are regulated by Hic-5. These will be cross-referenced to genes
that others have reported are markedly regulated in hypertrophic scars. Hic-5-dependent gene products
identified from these cDNA arrays will also be ,analyzed as candidate genes that eitlier reguiate the TGF-~
autocrine loop or mediate specific myofibroblast functions, Key gene products will then be incorporated
into quantitative PCR (qPCR) arrays and probed with RNA obtained from freshly resected hypertrophic
scars. Immunohistology will be employed to confirm the expression and localization of these Hic-5-
dependent gene products in scars. Findings obtained from this work will fill important gaps in
understanding pathogenic myofibroblast regulation and suggest new therapeutic strategies to modulate
fibrosis following serious burn or traumatic injury.
致病性瘢痕形成和纤维化是重要的临床问题,
对患者造成的后果,包括正常组织再生和邻近组织受损
功能我们的长期目标是确定控制成纤维细胞的关键调节机制,
分化成肌成纤维细胞,从而开发控制瘢痕形成和纤维化的新策略。转化生长因子
~是这种机制的核心成分,我们最近确定了一种粘着斑蛋白,
Hic-5在正常人皮肤成纤维细胞中由TGF-β 1诱导表达,Hic-5在正常人皮肤成纤维细胞中也持续表达。
增生性瘢痕肌成纤维细胞(HTSF)。重要的是,Hic-5是HTSF中TGF-α产生所必需的
从而通过TGF-β自分泌环调节其自身的表达。此外,当Hic-5被击倒时,
利用RNAi,HTSF表型回复到正常真皮成纤维细胞的表型,支持治疗性的
通过靶向肌成纤维细胞中Hic-5表达阻断纤维化的策略。我们提议一个为期两年,
ARRA赞助的研究项目中,我们测试了TGF-β诱导Hic-5表达的假设。
通过Rho GTP酶依赖性途径,从而建立自分泌环和持久的
肌成纤维细胞表型在目的1中,我们将定义调节TGF-β依赖性的细胞内途径,
肌成纤维细胞中的Hic-5表达。正常人Hic-5的诱导机制
成纤维细胞和致病性成纤维细胞(HTSF)
将被确定。实验将使用药理学抑制剂,遗传沉默
(RNAi)和cDNA重建。Hic-5和候选信号分子的水平将是
使用磷酸化特异性抗体测定活性变化。在目标2中,我们将
增生性瘢痕中Hic-,5调控基因的鉴定与分析。将使用表达(cDNA)阵列
鉴定HTSF中受Hic-5调控的基因产物。这些将被交叉引用到基因
在增生性瘢痕中有明显的调节。Hic-5依赖性基因产物
从这些cDNA阵列中鉴定的基因也将作为候选基因进行分析,这些候选基因也将调节TGF-β 1的表达。
自分泌环或介导特定的肌成纤维细胞功能,然后将纳入关键基因产物
定量PCR(qPCR)阵列,并用从新鲜切除的肥大细胞中获得的RNA进行探测。
伤疤将采用免疫组织学来确认这些Hic-5的表达和定位。
瘢痕中的依赖性基因产物。从这项工作中获得的结果将填补以下方面的重要空白:
了解致病性肌成纤维细胞调节,并提出新的治疗策略,
严重烧伤或创伤后纤维化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LIVINGSTON VAN DE WATER其他文献
LIVINGSTON VAN DE WATER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LIVINGSTON VAN DE WATER', 18)}}的其他基金
MATRIX REGULATION OF CELL FUNCTION DURING WOUND HEALING
伤口愈合过程中细胞功能的基质调节
- 批准号:
6386750 - 财政年份:1997
- 资助金额:
$ 26.22万 - 项目类别:
MATRIX REGULATION OF CELL FUNCTION DURING WOUND HEALING
伤口愈合过程中细胞功能的基质调节
- 批准号:
6446641 - 财政年份:1997
- 资助金额:
$ 26.22万 - 项目类别:
MATRIX REGULATION OF CELL FUNCTION DURING WOUND HEALING
伤口愈合过程中细胞功能的基质调节
- 批准号:
6614454 - 财政年份:1997
- 资助金额:
$ 26.22万 - 项目类别:
Matrix Regulation of Cell Function During Wound Healing
伤口愈合过程中细胞功能的基质调节
- 批准号:
7736841 - 财政年份:1997
- 资助金额:
$ 26.22万 - 项目类别:
MATRIX REGULATION OF CELL FUNCTION DURING WOUND HEALING
伤口愈合过程中细胞功能的基质调节
- 批准号:
2750176 - 财政年份:1997
- 资助金额:
$ 26.22万 - 项目类别:
Matrix Regulation of Cell Function During Wound Healing
伤口愈合过程中细胞功能的基质调节
- 批准号:
6919283 - 财政年份:1997
- 资助金额:
$ 26.22万 - 项目类别:
Matrix Regulation of Cell Function During Wound Healing
伤口愈合过程中细胞功能的基质调节
- 批准号:
7098119 - 财政年份:1997
- 资助金额:
$ 26.22万 - 项目类别:
MATRIX REGULATION OF CELL FUNCTION DURING WOUND HEALING
伤口愈合过程中细胞功能的基质调节
- 批准号:
6525413 - 财政年份:1997
- 资助金额:
$ 26.22万 - 项目类别:
Matrix Regulation of Cell Function During Wound Healing
伤口愈合过程中细胞功能的基质调节
- 批准号:
6822396 - 财政年份:1997
- 资助金额:
$ 26.22万 - 项目类别:
MATRIX REGULATION OF CELL FUNCTION DURING WOUND HEALING
伤口愈合过程中细胞功能的基质调节
- 批准号:
6199606 - 财政年份:1997
- 资助金额:
$ 26.22万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 26.22万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 26.22万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 26.22万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 26.22万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 26.22万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 26.22万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 26.22万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 26.22万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 26.22万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 26.22万 - 项目类别: